Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · IEX Real-Time Price · USD
40.68
-0.13 (-0.32%)
At close: Apr 19, 2024, 4:00 PM
40.69
+0.01 (0.02%)
After-hours: Apr 19, 2024, 4:29 PM EDT
Ionis Pharmaceuticals Market Cap
Ionis Pharmaceuticals has a market cap or net worth of $5.93 billion as of April 19, 2024. Its market cap has increased by 13.35% in one year.
Market Cap
5.93B
Enterprise Value
5.04B
1-Year Change
13.35%
Ranking
Category
Stock Price
$40.68
Market Cap Chart
Since December 1, 1998, Ionis Pharmaceuticals's market cap has increased from $302.10M to $5.93B, an increase of 1,862.66%. That is a compound annual growth rate of 12.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 5.95B | -0.24% |
Apr 17, 2024 | 5.96B | -1.52% |
Apr 16, 2024 | 6.05B | -0.02% |
Apr 15, 2024 | 6.06B | -0.46% |
Apr 12, 2024 | 6.08B | -1.79% |
Apr 11, 2024 | 6.19B | -1.02% |
Apr 10, 2024 | 6.26B | 0.26% |
Apr 9, 2024 | 6.24B | 1.40% |
Apr 8, 2024 | 6.16B | -2.27% |
Apr 5, 2024 | 6.30B | 0.91% |
Apr 4, 2024 | 6.24B | -2.17% |
Apr 3, 2024 | 6.38B | 1.81% |
Apr 2, 2024 | 6.27B | -2.14% |
Apr 1, 2024 | 6.40B | 1.36% |
Mar 28, 2024 | 6.32B | -2.93% |
Mar 27, 2024 | 6.51B | 1.25% |
Mar 26, 2024 | 6.43B | 0.45% |
Mar 25, 2024 | 6.40B | 2.79% |
Mar 22, 2024 | 6.23B | -0.07% |
Mar 21, 2024 | 6.23B | -0.07% |
Mar 20, 2024 | 6.24B | 1.47% |
Mar 19, 2024 | 6.14B | 0.31% |
Mar 18, 2024 | 6.13B | -1.22% |
Mar 15, 2024 | 6.20B | 0.88% |
Mar 14, 2024 | 6.15B | -2.27% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
The Ensign Group | 6.68B |
Elanco Animal Health | 6.61B |
Acadia Healthcare Company | 6.49B |
DENTSPLY SIRONA | 6.30B |
Revolution Medicines | 6.06B |
Apellis Pharmaceuticals | 5.79B |
Grifols | 5.56B |
Blueprint Medicines | 5.41B |